OptiNose Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:OPTN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Mar 25SellUS$1,380Michael MarinoIndividual246US$5.61
18 Mar 25SellUS$2,064Ramy MahmoudIndividual368US$5.61
04 Mar 25SellUS$6,470Paul SpenceIndividual1,223US$5.29
04 Mar 25SellUS$11,347Michael MarinoIndividual2,145US$5.29
04 Mar 25SellUS$33,729Ramy MahmoudIndividual6,376US$5.29
17 Dec 24SellUS$1,342Michael MarinoIndividual203.33US$6.60
17 Dec 24SellUS$2,030Ramy MahmoudIndividual307.6US$6.60
17 Sep 24SellUS$4,246Ramy MahmoudIndividual325.4US$13.05
17 Sep 24SellUS$2,807Michael MarinoIndividual215.07US$13.05
17 Jul 24SellUS$127,026Ramy MahmoudIndividual7,428.4US$17.10
17 Jul 24SellUS$56,325Michael MarinoIndividual3,293.87US$17.10
17 Jul 24SellUS$7,803Anthony KrickIndividual456.33US$17.10
18 Jun 24SellUS$22,595Ramy MahmoudIndividual1,265.8US$17.85
18 Jun 24SellUS$3,888Michael MarinoIndividual217.8US$17.85
18 Jun 24SellUS$3,506Michael MarinoIndividual196.4US$17.85
18 Jun 24SellUS$743Anthony KrickIndividual41.6US$17.85

Insider Trading Volume

Insider Buying: OPTN insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of OPTN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders543,0075.36%
VC/PE Firms973,6849.61%
Hedge Funds2,095,17320.7%
General Public2,769,04527.3%
Institutions3,746,47237%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 71.91% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.6%
FMR LLC
1,076,506US$10.2m0.4%no data
9.74%
Nantahala Capital Management, LLC
986,031US$9.4m3.02%0.69%
9.61%
MVM Partners LLP
973,684US$9.3m0%52.38%
5.81%
Stonepine Capital Management LLC
588,657US$5.6m55.2%2.42%
5.14%
Kingdon Capital Management, L.L.C.
520,485US$5.0m39.4%0.89%
4.8%
Theodore Kruttschnitt
486,000US$4.6m0%no data
4.17%
Acorn Bioventures
422,813US$4.0m-6.44%2.96%
3.66%
Great Point Partners, LLC
370,269US$3.5m-55.6%1.89%
3.29%
D. E. Shaw & Co., L.P.
333,333US$3.2m0%no data
2.9%
The Vanguard Group, Inc.
294,104US$2.8m14.5%no data
2.66%
Bleichroeder LP
269,675US$2.6m0%0.69%
2.53%
Rosalind Advisors, Inc.
256,190US$2.4m-70.8%0.94%
1.55%
Easterly Investment Partners LLC
156,666US$1.5m236%0.11%
0.89%
Geode Capital Management, LLC
89,684US$853.8k4.08%no data
0.73%
GMT Capital Corp.
74,047US$704.9k0%0.02%
0.68%
Susquehanna International Group, LLP, Asset Management Arm
68,461US$651.7k155%no data
0.59%
Prescott Group Capital Management L.L.C.
60,135US$572.5k-0.01%0.07%
0.47%
BlackRock, Inc.
47,988US$456.8k-14.1%no data
0.46%
Rice Hall James & Associates, LLC
46,453US$442.2k-37.6%0.02%
0.34%
Ramy Mahmoud
34,163US$325.2k42.3%no data
0.28%
Jane Street Group, LLC, Asset Management Arm
28,560US$271.9k913%no data
0.28%
State Street Global Advisors, Inc.
28,030US$266.8k23.2%no data
0.24%
Prelude Capital Management, LLC
24,000US$228.5k0%0.02%
0.24%
Cheyne Capital Management (UK) LLP
23,957US$228.1k0%9.0%
0.22%
Deltec Asset Management LLC
22,500US$214.2k0%0.04%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 21:51
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OptiNose, Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gary NachmanBMO Capital Markets Equity Research
Matthew CaufieldH.C. Wainwright & Co.
Glen SantangeloJefferies LLC